UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report: August 26, 2015
(Date of earliest event reported)
MusclePharm Corporation
(Exact name of registrant as specified in
its charter)
NEVADA |
|
000-53166 |
|
77-0664193 |
(State or other jurisdiction of incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
4721 Ironton Street, Building A
Denver, Colorado 80239
(Address of principal executive offices)
(Zip Code)
(303) 396-6100
(Registrant’s telephone number, including
area code)
N/A
(Former name or former address, if changed
since last report)
Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
(see General Instruction A.2. below):
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-14(c)).
| Item 5.02. | Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers |
On August 26, 2015,
the Board of Directors (the “Board”) of MusclePharm Corporation, a Nevada corporation (the “Company”),
appointed its current Chairman of the Board, Mr. Ryan Drexler, as its Executive Chairman of the Board to hold office until
the next annual meeting or until his successor is duly elected and qualified with all the duties as set forth for the position
of the Chief Executive Officer in the Company’s Bylaws and other governance documents duly adopted or that may be adopted
by the Company. Mr. Drexler shall receive compensations as further determined by the Board or the Compensation Committee of the
Board.
Subsequent to the Meeting
(as defined below), the Board reaffirmed Brad Pyat as the Chief Executive Officer, Richard Estalella as the President, John Price
as the Chief Financial Officer and Cory Gregory as the Executive Vice President. In addition, as a result of re-election, the composition
of the committees of the Board is reaffirmed. As such, the Company’s Audit Committee is currently comprised of Mr. Bush as
the Chair, Mr. Doron, and Mr. Jenkins. The Company’s Compensation Committee is currently comprised of Mr. Doron as the Chair,
Mr. Thompson and Mr. Bush. The Company’s Nominating & Governance Committee is currently comprised of Mr. Jenkins as the
Chair, Mr. Thompson and Mr. Doron. The Company’s Strategic Initiative Committee is currently comprised of Mr. Thompson as
the Chair, Mr. Estalella, Mr. Doron and Mr. Jenkins.
| ITEM 5.03 | AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE
IN FISCAL YEAR |
The Board adopted an
amendment to the Company’s amended and restated Bylaws effective as of August 26, 2015 (the “Amendment”). The
following is a summary of changes effected by adoption of the Amendment, which summary is qualified in its entirety by reference
to the Amendment filed as Exhibit 3.01 hereto. In addition to the changes summarized below, the new bylaws reflect certain non-substantive
changes for consistency:
Article IV –
Officers
| · | Various provisions related to officer positions and reporting relationships
are modified to create a position of Executive Chairman and clarify the powers and duties of the officers. The Executive Chairmen
shall have such powers and perform such duties as may be assigned by the Board of Directors. The Chief Executive Officer shall
supervise and direct generally all the business and affairs of the Company. The President shall have such powers and perform such
duties as may be assigned by the Board of Directors, the Executive Chairman, or the Chief Executive Officer. (Section 5). |
| Item 5.07. | Submission of Matters to a Vote of Security Holders. |
On August 26 2015,
the Company held its 2015 Annual Meeting of Stockholders (the “Meeting”).
As of June 23, 2015,
the record date for the Meeting, there were 13,776,381 shares of the Company’s common stock entitled to vote.
At the Meeting, the
shareholders voted on the following six proposals and cast their votes as follows:
1. To elect Directors,
the seven (7) persons named herein as nominees for directors of the Company, to hold office until the next annual meeting of stockholders
and until their respective successors have been duly elected and qualified including Bradley J. Pyatt, William Bush, Noel Thompson,
Ryan Drexler, Richard F. Estalella, Michael J. Doron and Stacy Jenkins.
| |
FOR | | |
WITHHELD | |
Bradley J. Pyatt | |
| 5,108,535 | | |
| 1,471,438 | |
William Bush | |
| 6,020,075 | | |
| 559,898 | |
Noel Thompson | |
| 4,389,430 | | |
| 2,190,543 | |
Ryan Drexler | |
| 6,187,567 | | |
| 392,406 | |
Richard Estalella | |
| 5,420,622 | | |
| 1,159,351 | |
Michael Doron | |
| 5,303,055 | | |
| 1,276,918 | |
Stacy Jenkins | |
| 6,008,408 | | |
| 571,565 | |
2. To ratify the appointment
of EKS&H LLP as the Company’s independent auditors for the fiscal year ending December 31, 2015.
| |
FOR | | |
AGAINST | | |
ABSTAIN | |
# of Shares Cast/Voted | |
| 9,470,857 | | |
| 380,186 | | |
| 51,316 | |
3. To approve the Company’s
2015 Equity Incentive Plan (“ESOP”)
|
|
FOR |
|
|
AGAINST |
|
|
ABSTAIN |
|
# of Shares Cast/Voted |
|
|
4,028,185 |
|
|
|
2,110,067 |
|
|
|
441,721 |
|
4. To Approve the Company’s
2015 Employee Stock Purchase Plan (“ESPP”)
|
|
FOR |
|
|
AGAINST |
|
|
ABSTAIN |
|
# of Shares Cast/Voted |
|
|
4,773,924 |
|
|
|
1,219,673 |
|
|
|
586,376 |
|
5. To hold an advisory
vote on the executive compensation:
|
|
FOR |
|
|
AGAINST |
|
|
ABSTAIN |
|
# of Shares Cast/Voted |
|
|
5,935,312 |
|
|
|
622,315 |
|
|
|
22,346 |
|
6. To hold an advisory
vote on the frequency of the advisory vote of executive compensation:
| |
ONE YEAR | | |
TWO YEARS | | |
THREE YEARS | | |
ABSTAIN | |
# of Shares Cast/Voted | |
| 4,935,939 | | |
| 406,729 | | |
| 973,904 | | |
| 263,401 | |
Accordingly, the proposals
1-5 were approved and the proposal 6 was voted for “One Year” frequency.
| ITEM 9.01 | FINANCIAL STATEMENTS AND EXHIBITS |
The exhibit listed in the following Exhibit Index is filed as
part of this Current Report on Form 8-K.
Exhibit No. |
Description |
|
|
|
|
3.01 |
Amendment to the Amended and Restated Bylaws of MusclePharm Corporation, effective as of August 26, 2015 |
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
MUSCLEPHARM CORPORATION |
|
|
|
|
|
Dated: September 1, 2015 |
|
|
|
|
By: |
/s/ Brad J. Pyatt |
|
|
Name: |
Brad J. Pyatt |
|
|
Title: |
Chief Executive Officer and President |
|
Exhibit 3.1
AMENDMENT TO THE AMENDED AND RESTATED
BY-LAWS
OF
MUSCLEPHARM CORPORATION
The Amended and Restated By-Laws (the “Bylaws”)
of MUSCLEPHARM CORPORATION, a Nevada corporation (the “Corporation”), as certified by the secretary of the Corporation
on August 26, 2015, are hereby amended as follows:
Section 1 to Article III of the Bylaws is amended and restated
as follows:
“Section 1. Number and Election of Directors. The
Board of Directors shall consist of a minimum of one member and a maximum of nine members, the exact number of which shall be fixed
by the Board of Directors, with one director serving as the Executive Chairman of the Board of Directors. The number of directors
may be increased above nine by action of the stockholders or directors. Except as provided in Section 2 of this Article, directors
shall be elected by a plurality of the votes cast at Annual Meetings of Stockholders, and each director so elected shall hold office
until the next Annual Meeting and until his successor is duly elected and qualified, or until his earlier resignation or removal.
Any director may resign at any time upon written notice to the Corporation. Directors need not be stockholders.”
Article IV of the Bylaws is amended and restated as follows:
ARTICLE IV
OFFICERS
Section 1. General. The
officers of the Corporation shall be chosen by the Board of Directors and shall be an Chief Executive Officer, a President, a Secretary
and a Treasurer. The Board of Directors, in its discretion, may also choose a Chairman of the Board of Directors (who must be a
director and may be an Executive Chairman), and one or more Vice Presidents, Assistant Secretaries, Assistant Treasurers and other
officers. Any number of offices may be held by the same person, unless otherwise prohibited by law, the Articles of Incorporation
or these By-Laws. The officers of the Corporation need not be stockholders of the Corporation nor, except in the case of the Chairman
of the Board of Directors, need such officers be directors of the Corporation.
Section 2. Election. The
Board of Directors at its first meeting held after each Annual Meeting of Stockholders shall elect the officers of the Corporation
who shall hold their offices for such terms and shall exercise such powers and perform such duties as shall be determined from
time to time by the Board of Directors; and all officers of the Corporation shall hold office until their successors are chosen
and qualified, or until their earlier resignation or removal. Any officer elected by the Board of Directors may be removed at any
time by the affirmative vote of a majority of the Board of Directors. Any vacancy occurring in any office of the Corporation shall
be filled by the Board of Directors. The salaries of all officers of the Corporation shall be fixed by the Board of Directors.
Section 3. Voting Securities
Owned by the Corporation. Powers of attorney, proxies, waivers of notice of meeting, consents and other instruments relating
to securities owned by the Corporation may be executed in the name of and on behalf of the Corporation by the President or any
Vice President and any such officer may, in the name of and on behalf of the Corporation, take all such action as any such officer
may deem advisable to vote in person or by proxy at any meeting of security holders of any corporation in which the Corporation
may own securities and at any such meeting shall possess and may exercise any and all rights and power incident to the ownership
of such securities and which, as the owner thereof, the Corporation might have exercised and possessed if present. The Board of
Directors may, by resolution, from time to time confer like powers upon an-other person or persons.
Section 4. Chairman of the
Board of Directors. The Chairman of the Board of Directors, if there be one, shall preside at all meetings of the stockholders
and of the Board of Directors. The Chairman of the Board of Directors shall also perform such other duties and may exercise such
other powers as from time to time may be assigned to him by these By-Laws or by the Board of Directors.
Section 5. Executive Chairman,
Chief Executive Officer and President. Subject to the control of the Board of Directors, the Chief Executive Officer shall
supervise and direct generally all the business and affairs of the Corporation. The Executive Chairman shall have such powers and
perform such duties as may be assigned by the Board of Directors. The President shall have such powers and perform such duties
as may be assigned by the Board of Directors, the Executive Chairman, or the Chief Executive Officer. In case of the absence or
disability of the Chief Executive Officer or a vacancy in the office, the President shall exercise all the powers and perform all
the duties of the Chief Executive Officer. The Board of Directors may elect one or more persons to be the President and/or Chief
Executive Officer of a division or business unit of the Corporation.
Section 6. Vice-Presidents. At
the request of the President or in his absence or in the event of his inability or refusal to act, the Vice-President or the Vice-Presidents
if there is more than one (in the order designated by the Board of Directors) shall perform the duties of the President, and when
so acting, shall have all the powers of and be subject to all the restrictions upon the President. Each Vice-President shall perform
such other-duties and have such other powers as the Board of Directors, the Chief Executive Officer, the Chief Executive Officer,
or the President from time to time may prescribe. If there be no Vice-President, the Board of Directors shall designate the officer
of the Corporation who, in the absence of the President or in the event of the inability or refusal of the President to act, shall
perform the duties of the President, and when so acting, shall have all the powers of and be subject to all the restrictions upon
the President.
Section 7. Secretary. The
Secretary shall attend all meetings of the Board of Directors and all meetings of stockholders and record all the proceedings thereat
in a book or books to be kept for that purpose; the Secretary shall also perform like duties for the standing committees when required.
The Secretary shall give, or cause to be given, notice of all meetings of the stockholders and special meetings of the Board of
Directors, and shall perform such other duties as may be prescribed by the Board of Directors, the Executive Chairman, the Chief
Executive Officer, or President, under whose supervision he shall be. If the Secretary shall be unable or shall refuse to cause
to be given notice of all meetings of the stockholders and special meetings of the Board of Directors, and if there be no Assistant
Secretary, then either the Board of Directors or the President may choose another officer to cause such notice to be given. The
Secretary shall have custody of the seal of the Corporation and the Secretary or any Assistant Secretary, if there be one, shall
have authority to affix the same to any instrument requiring it and when so affixed, it may be attested by the signature of the
Secretary or by the signature of any such Assistant Secretary. The Board of Directors may give general authority to any' other
officer to affix the seal of the Corporation and to attest the affixing by his signature. The Secretary shall see that all books,
reports, statements, certificates and other documents and records required by Law to be kept or filed are properly kept or filed,
as the case may be.
Section 8. Treasurer. The
Treasurer shall have the custody of the corporate funds and securities and shall keep full and accurate accounts of receipts and
disbursements in books belonging to the Corporation and shall deposit all moneys and other valuable effects in the name and to
the credit of the Corporation in such depositories as may be designated by the Board of Directors. The Treasurer shall disburse
the funds of the Corporation as may be ordered by the Board of Directors, taking proper vouchers for such disbursements, and shall
render unto the President and the Board of Directors, at its regular meetings, or when the Board of Directors so requires, an account
of all his transactions as Treasurer and of the financial condition of the Corporation. If required by the Board of Directors,
the Treasurer shall give the Corporation a bond in such sum and with such surety or sureties as shall be satisfactory to the Board
of Directors for the faithful performance of the duties of his office and for the restoration to the Corporation, in case of his
death, resignation, retirement or removal from office, of all books, papers, vouchers, money and other property of whatever kind
in his possession or under his control belonging to the Corporation.
Section 9. Assistant Secretaries. Except
as may be otherwise provided in these By-Laws, Assistant Secretaries, if there be any, shall perform such duties and have such
powers as from time to time may be assigned to them by the Board of Directors, the Executive Chairman, the President, any Vice-President,
if there be one, or the Secretary, and in the absence of the Secretary or in the event of his disability or refusal to act, shall
perform the duties of the Secretary, and when so acting, shall have all the powers of and be subject to all the restrictions upon
the Secretary.
Section 10. Assistant Treasurers. Assistant
Treasurers, if there be any, shall perform such duties and have such powers as from time to time may be assigned to them by the
Board of Directors, the Executive Chairman, Chief Executive Officer, or the President, any Vice-President, if there be one, or
the Treasurer, and in the absence of the Treasurer or in the event of his disability or refusal to act, shall perform the duties
of the Treasurer, and when so acting, shall have all the powers of and be subject to all the restrictions upon the Treasurer. If
required by the Board of Directors, an Assistant Treasurer shall give the Corporation a bond in such sum and with such surety or
sureties as shall be satisfactory to the Board of Directors for the faithful performance of the duties of his office and for the
restoration to the Corporation, in case of his death, resignation, retirement or removal from office, of all books, papers, vouchers,
money and other property of whatever kind in his possession or under his control belonging to the Corporation.
Section 11. Other Officers. Such
other officers as the Board of Directors may choose shall perform such duties and have such powers as from time to time may be
assigned to them by the Board of Directors. The Board of Directors may delegate to any other officer of the Corporation the power
to choose such other officers and to prescribe their respective duties and powers.
CERTIFICATION
I hereby certify that I am the duly appointed and acting Secretary
of MUSCLEPHARM CORPORATION and that the foregoing amendment to the Amended and Restated Bylaws of MUSCLEPHARM CORPORATION was duly
adopted and approved by unanimous written consent of the Board of Directors held on the date set forth above.
Dated this 26th day of August 2015. |
|
|
|
/s/John Price |
|
John Price, Secretary |
|
Muscle Pharm (CE) (USOTC:MSLP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Muscle Pharm (CE) (USOTC:MSLP)
Historical Stock Chart
From Apr 2023 to Apr 2024